KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Accumulated Expenses (2016 - 2025)

Hologic's Accumulated Expenses history spans 17 years, with the latest figure at $570.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 7.93% year-over-year to $570.0 million; the TTM value through Dec 2025 reached $570.0 million, up 7.93%, while the annual FY2025 figure was $577.7 million, 0.35% changed from the prior year.
  • Accumulated Expenses for Q4 2025 was $570.0 million at Hologic, down from $577.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $632.4 million in Q4 2021 and bottomed at $484.0 million in Q4 2023.
  • The 5-year median for Accumulated Expenses is $539.8 million (2022), against an average of $551.4 million.
  • The largest annual shift saw Accumulated Expenses surged 46.15% in 2021 before it fell 17.48% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $632.4 million in 2021, then fell by 14.77% to $539.0 million in 2022, then dropped by 10.2% to $484.0 million in 2023, then rose by 9.11% to $528.1 million in 2024, then rose by 7.93% to $570.0 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Accumulated Expenses are $570.0 million (Q4 2025), $577.7 million (Q3 2025), and $553.7 million (Q2 2025).